Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Littleton, CO
NPI: 1265675433Primary Employer
Rocky Mountain Cancer Centers LLP
rockymountaincancercenters.com
HQ Phone
Get M.D. Manojkumar's Phone Numberphone_androidMobile
Get M.D. Manojkumar's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCO State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 36415Insertion of needle into vein for collection of blood sample | 533 | 2,117 |
| 2 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 519 | 2,139 |
| 3 | 80053Blood test, comprehensive group of blood chemicals | 489 | 1,855 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 377 | 966 |
| 5 | 82378Carcinoembryonic antigen (CEA) protein level | 273 | 695 |
Authors: Scott Tagawa, Rohit Jain, Arjun Balar, Phillip Palmbos, Petros Grivas, Rohit Jain
Journal: Clin Cancer Res
Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experience.
Authors: Daniel Karp, Joud Hajjar, Funda Meric
Publication Date: 2016-06-23
Authors: Scott Tagawa, Rohit Jain, Arjun Balar, Phillip Palmbos, Petros Grivas, Sumati Gupta, Rohit Jain
Journal: Future Oncol
Publication Date: 2024-06-05
Lead Sponsor: Sutro Biopharma, Inc.
Intervention / Treatment: DRUG: STRO-002
Lead Sponsor: G1 Therapeutics, Inc.
Intervention / Treatment: DRUG: Carboplatin, DRUG: Cisplatin, DRUG: Gemcitabine, DRUG: Avelumab, DRUG: Trilaciclib
Lead Sponsor: CanariaBio Inc.
Collaborators: Iqvia Pty Ltd, Gynecologic Oncology Group
Intervention / Treatment: DRUG: Carboplatin, BIOLOGICAL: Placebo, DRUG: Paclitaxel, BIOLOGICAL: Oregovomab